High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial). [electronic resource]
Producer: 20110907Description: 119-27 p. digitalISSN:- 1528-0012
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Chi-Square Distribution
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- diagnosis
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interferons
- Interleukins -- genetics
- Linear Models
- Logistic Models
- Male
- Middle Aged
- Odds Ratio
- Phenotype
- Polyethylene Glycols -- administration & dosage
- RNA, Viral -- blood
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.